Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SKINSkinHealth Systems Inc.

Nasdaq · CIK 0001818093
Filer categoryAccelerated filer
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts374

Identity from submissions API

NameSkinHealth Systems Inc.
CIK0001818093
TickersSKIN
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC3841 Surgical & Medical Instruments & Apparatus
EIN851908962
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone800-603-4996
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Beauty Health Co (2021-01-29T05:00:00.000Z → 2026-04-20T04:00:00.000Z)
  • Vesper Healthcare Acquisition Corp. (2020-08-12T04:00:00.000Z → 2021-04-30T04:00:00.000Z)
Business address
3600 E. BURNETT STREET
LONG BEACH
CA
90815
CA
Mailing address
3600 E. BURNETT STREET
LONG BEACH
CA
90815
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

442 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-124598 005-91732 261537060 34 19824
2026-11-05 10-Q 10-Q 0001628280-26-071173 001-39565 261528523 34 6729758 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001628280-26-071066 001-39565 261527507 34 597306 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002881 005-91732 261526340 34 11694
2026-10-14 8-K 8-K 3.03,5.03,7.01,9.01 0001628280-26-065833 001-39565 261458454 34 254629 1 1
2026-10-13 4 FORM 4 0001628280-26-065692 6539
2026-10-06 8-K 8-K 1.02,7.01 0001628280-26-065232 001-39565 261444028 34 177708 1 1
2026-09-28 8-K 8-K 5.07 0001628280-26-063712 001-39565 261417245 34 183956 1 1
2026-09-10 8-K 8-K 5.02 0001628280-26-061326 001-39565 261371092 34 177679 1 1
2026-08-14 8-K 8-K 5.02 0001628280-26-057096 001-39565 261281252 34 174915 1 1
2026-08-12 4 FORM 4 0001628280-26-056277 5104
2026-08-12 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS 0001683168-26-006276 001-39565 261267571 34 326247
2026-08-12 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-26-006273 001-39565 261267425 34 566064
2026-08-06 10-Q 10-Q 0001628280-26-054476 001-39565 261250447 34 6497933 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001628280-26-054309 001-39565 261249122 34 595400 1 1
2026-07-31 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-26-005869 001-39565 261228432 34 1053591
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002253 005-91732 261206087 34 10916
2026-07-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-000738 005-91732 261182494 34 10940
2026-07-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001901361-26-000011 005-91732 261169996 34 7319
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001466 005-91732 261161034 34 11319
2026-06-22 8-K 8-K 8.01 0001628280-26-044620 001-39565 261107046 34 186117 1 1
2026-06-16 8-K 8-K 5.07 0001628280-26-043539 001-39565 261094711 34 200231 1 1
2026-05-21 8-K/A 8-K/A 5.02,9.01 0001628280-26-037340 001-39565 261009248 34 244382 1 1
2026-05-20 144 xsl144X01/primary_doc.xml 0001959173-26-003840 001-39565 261004369 33 5206
2026-05-12 8-K 8-K 3.01 0001628280-26-034101 001-39565 26968534 34 185042 1 1
2026-05-11 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-217467 005-91732 26965115 34 17496
2026-05-07 10-Q 10-Q 0001628280-26-032326 001-39565 26954885 34 5764317 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001628280-26-032099 001-39565 26953319 34 484084 1 1
2026-05-06 8-K 8-K 5.02 0001628280-26-031243 001-39565 26948319 34 177225 1 1
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001102 005-91732 26946567 34 11487
2026-04-24 ARS ANNUAL REPORT 0001683168-26-003190 001-39565 26893895 34 1122040
2026-04-24 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-26-003189 001-39565 26893869 34 3914515 1 1
2026-04-22 3 FORM 3 0001628280-26-026560 423930
2026-04-22 3 FORM 3 0001628280-26-026559 423866
2026-04-22 3 FORM 3 0001628280-26-026557 422673
2026-04-22 8-K 8-K 5.02,5.03,7.01,9.01 0001628280-26-026555 001-39565 26883926 34 683278 1 1
2026-04-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-045554 005-91732 26875839 34 18934
2026-04-13 4 FORM 4 0001628280-26-024902 5022
2026-04-13 4 FORM 4 0001628280-26-024900 4990
2026-03-24 4 FORM 4 0001628280-26-020850 5357
2026-03-24 4 FORM 4 0001628280-26-020849 5331
2026-03-24 4 FORM 4 0001628280-26-020848 5353
2026-03-24 4 FORM 4 0001628280-26-020847 5363
2026-03-19 4 FORM 4 0001628280-26-019785 4950
2026-03-19 4 FORM 4 0001628280-26-019783 4941
2026-03-19 4 FORM 4 0001628280-26-019782 4919
2026-03-12 10-K 10-K 0001628280-26-017376 001-39565 26749086 34 13057637 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001628280-26-017222 001-39565 26747579 34 605817 1 1
2026-03-06 8-K 8-K 8.01,9.01 0001628280-26-015640 001-39565 26731540 34 5099627 1 1
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-000506 005-91732 26605610 34 7219
2026-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001901361-26-000007 005-91732 26600386 34 7038
2025-12-05 144 xsl144X01/primary_doc.xml 0001959173-25-007547 001-39565 251552165 33 4944
2025-11-17 4 FORM 4 0001628280-25-052601 5257
2025-11-06 10-Q 10-Q 0001628280-25-050315 001-39565 251459582 34 6350980 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001628280-25-050171 001-39565 251458362 34 492916 1 1
2025-11-04 4 FORM 4 0001628280-25-048959 4869
2025-11-03 3 FORM 3 0001628280-25-048236 428280
2025-11-03 8-K 8-K 5.02,7.01,9.01 0001628280-25-048229 001-39565 251444186 34 231990 1 1
2025-10-17 8-K/A 8-K/A 5.02,9.01 0001628280-25-045385 001-39565 251401495 34 247406 1 1
2025-10-10 4 FORM 4 0001628280-25-044806 6397
2025-10-10 3 FORM 3 0001628280-25-044804 390771
2025-09-30 8-K 8-K 5.02,7.01,9.01 0001628280-25-043256 001-39565 251360968 34 26212863 1 1
2025-09-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004121 005-91732 251298821 34 7203
2025-09-04 8-K FORM 8-K 1.01,9.01 0001683168-25-006690 001-39565 251293787 34 265320 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000201 005-91732 251215469 34 9580
2025-08-12 4 FORM 4 0001628280-25-039897 4850
2025-08-07 10-Q 10-Q 0001628280-25-038993 001-39565 251195354 34 7801051 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001628280-25-038879 001-39565 251194117 34 488187 1 1
2025-08-01 8-K 8-K 5.03,8.01,9.01 0001628280-25-037230 001-39565 251176182 34 198779 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003136 005-91732 251132329 34 10800
2025-07-01 144 xsl144X01/primary_doc.xml 0001628280-25-033756 001-39565 251096342 33 4303
2025-06-18 4 FORM 4 0001628280-25-032142 5008
2025-06-18 4 FORM 4 0001628280-25-032141 7368
2025-06-18 4 FORM 4 0001628280-25-032140 5032
2025-06-18 4 FORM 4 0001628280-25-032139 5006
2025-06-18 4 FORM 4 0001628280-25-032138 4991
2025-06-18 4 FORM 4 0001628280-25-032135 5055
2025-06-17 8-K 8-K 5.07 0001628280-25-031820 001-39565 251053274 34 198147 1 1
2025-06-03 4 FORM 4 0001628280-25-029044 4850
2025-05-27 8-K FORM 8-K 1.01,2.03,3.02,9.01 0001683168-25-004033 001-39565 25989955 34 1656920 1 1
2025-05-21 8-K 8-K 1.01,3.02,7.01,9.01 0001683168-25-003922 001-39565 25973283 34 1914717 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000133 005-91732 25943815 34 10696
2025-05-08 10-Q 10-Q 0001628280-25-023922 001-39565 25927402 34 5779005 1 1
2025-05-08 8-K 8-K 2.02,9.01 0001628280-25-023780 001-39565 25926043 34 424530 1 1
2025-04-25 ARS FORM ARS 0001683168-25-002841 001-39565 25874730 34 1017200
2025-04-25 DEF 14A DEFINITIVE PROXY 0001683168-25-002840 001-39565 25874595 34 3685800 1 1
2025-04-11 4 FORM 4 0001628280-25-017556 4876
2025-04-11 4 FORM 4 0001628280-25-017550 4888
2025-04-11 4 FORM 4 0001628280-25-017546 4849
2025-03-19 4 FORM 4 0001628280-25-013885 4992
2025-03-19 4 FORM 4 0001628280-25-013884 4984
2025-03-19 4 FORM 4 0001628280-25-013882 5005
2025-03-19 4 FORM 4 0001628280-25-013881 4965
2025-03-12 10-K 10-K 0001628280-25-012407 001-39565 25732783 34 11194896 1 1
2025-03-12 8-K 8-K 2.02,9.01 0001628280-25-012343 001-39565 25731813 34 517724 1 1
2025-02-28 3 FORM 3 0001628280-25-009074 433988
2025-02-28 3 FORM 3 0001628280-25-009065 432941
2025-02-28 8-K 8-K 5.02,7.01,9.01 0001628280-25-009050 001-39565 25690567 34 321085 1 1
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000014 005-91732 25599945 34 10690
2025-01-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000443 005-91732 25576869 34 7044
2024-12-30 3 FORM 3 0001628280-24-052601 432101
2024-12-17 8-K 8-K 5.02,7.01,9.01 0001628280-24-051683 001-39565 241556182 34 208228 1 1
2024-12-03 4 FORM 4 0001628280-24-049743 4856
2024-11-21 4 FORM 4 0001628280-24-048855 4562
2024-11-14 SC 13G/A beauty13ga3-11142024.htm 0001013594-24-000974 005-91732 241462599 34 175381
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000105 005-91732 241458797 34 13095
2024-11-14 SC 13G/A d11528089_13g-a.htm 0000919574-24-006606 005-91732 241458569 34 148547
2024-11-12 10-Q 10-Q 0001628280-24-047310 001-39565 241449973 34 6236949 1 1
2024-11-12 8-K 8-K 2.02,9.01 0001628280-24-047122 001-39565 241448062 34 510441 1 1
2024-11-12 8-K/A 8-K/A 5.02,9.01 0001628280-24-047098 001-39565 241447731 34 263626 1 1
2024-11-12 SC 13G/A UnitedStates_13G__BeautyHeal.txt 0000932471-24-000898 005-91732 241446586 34 6642
2024-11-12 SC 13G/A filing.txt 0000315066-24-002619 005-91732 241444394 34 8585
2024-11-04 SC 13G/A UnitedStates_13G__BeautyHeal.txt 0000932471-24-000367 005-91732 241421539 34 5712
2024-10-15 8-K 8-K 5.02 0001628280-24-042835 001-39565 241372046 34 184570 1 1
2024-08-30 8-K 8-K 5.02 0001628280-24-038962 001-39565 241270350 34 183229 1 1
2024-08-13 4 FORM 4 0001628280-24-036967 6889
2024-08-13 4 FORM 4 0001628280-24-036963 4856
2024-08-08 10-Q 10-Q 0001628280-24-036238 001-39565 241189598 34 6455734 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001628280-24-036121 001-39565 241188244 34 506533 1 1
2024-07-10 4 FORM 4 0001628280-24-031610 5015
2024-07-10 4 FORM 4 0001628280-24-031601 5013
2024-07-10 4 FORM 4 0001628280-24-031597 4998
2024-07-10 4 FORM 4 0001628280-24-031595 5039
2024-07-10 4 FORM 4 0001628280-24-031592 5035
2024-07-10 4 FORM 4 0001628280-24-031589 5095
2024-07-10 4 FORM 4 0001628280-24-031586 14616
2024-06-11 4 FORM 4 0001628280-24-027739 9428
2024-06-11 4 FORM 4 0001628280-24-027737 10540
2024-06-11 8-K 8-K 5.03,5.07,9.01 0001628280-24-027695 001-39565 241036459 34 251788 1 1
2024-05-17 SC 13G d11052496_13-g.htm 0000919574-24-003248 005-91732 24961599 34 125850
2024-05-09 10-Q 10-Q 0001628280-24-022336 001-39565 24931926 34 8797960 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001628280-24-022209 001-39565 24930539 34 434023 1 1
2024-05-02 8-K/A 8-K/A 5.02,9.01 0001628280-24-019980 001-39565 24908028 34 258847 1 1
2024-04-26 ARS ANNUAL REPORT 0001683168-24-002720 001-39565 24880739 34 1064338
2024-04-26 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-24-002718 001-39565 24880719 34 3486781 1 1
2024-04-11 4 FORM 4 0001628280-24-015847 4980
2024-04-11 4 FORM 4 0001628280-24-015844 4965
2024-04-11 4 FORM 4 0001628280-24-015842 5005
2024-04-10 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-24-002278 001-39565 24836367 34 3507124 1 1
2024-04-09 8-K 8-K 5.02 0001628280-24-015457 001-39565 24832970 34 183673 1 1
2024-04-08 8-K 8-K 5.02,8.01,9.01 0001628280-24-015295 001-39565 24830451 34 16542035 1 1
2024-04-05 SC 13G/A JHG PLC OWNS 10% 0001274173-24-000065 005-91732 24825811 34 13098
2024-03-14 SC 13D/A SC 13D/A 0001193125-24-067917 005-91732 24750330 34 120941
2024-03-12 10-K 10-K 0001628280-24-010638 001-39565 24743381 34 14522783 1 1
2024-03-12 8-K 8-K 2.02,9.01 0001628280-24-010538 001-39565 24742186 34 532798 1 1
2024-03-12 8-K 8-K 7.01,8.01,9.01 0001628280-24-010531 001-39565 24742120 34 208489 1 1
2024-02-29 NT 10-K NT 10-K 0001628280-24-008000 001-39565 24704162 34 33273
2024-02-14 SC 13G/A beauty13ga2-02142024.htm 0001013594-24-000188 005-91732 24638134 34 212608
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020413 005-91732 24627685 34 13167
2024-02-13 SC 13G/A JHG PLC OWNS >5% 0001274173-24-000045 005-91732 24624859 34 13091
2024-02-09 SC 13G/A THE BEAUTY HEALTH COMPANY 0000902664-24-001371 005-91732 24615190 34 59364
2024-01-10 SC 13G/A filing.txt 0000315066-24-000035 005-91732 24524988 34 8375
2023-12-14 8-K/A 8-K/A 5.02,9.01 0001628280-23-041578 001-39565 231487073 34 462371 1 1
2023-12-11 SC 13G/A filing.txt 0000315066-23-002806 005-91732 231477042 34 8208
2023-12-01 4 FORM 4 0001628280-23-040452 4950
2023-12-01 4 FORM 4 0001628280-23-040451 4979
2023-12-01 4 FORM 4 0001628280-23-040446 4935
2023-12-01 8-K 8-K 5.02,9.01 0001628280-23-040443 001-39565 231459639 34 262060 1 1
2023-11-21 4 FORM 4 0001628280-23-039740 5085
2023-11-16 8-K 8-K 2.05 0001628280-23-039265 001-39565 231413046 34 193335 1 1
2023-11-14 10-Q 10-Q 0001628280-23-038926 001-39565 231406057 34 6833301 1 1
2023-11-13 NT 10-Q NT 10-Q 0001628280-23-038623 001-39565 231399031 34 27772
2023-11-13 8-K 8-K 2.02,9.01 0001628280-23-038610 001-39565 231398803 34 541761 1 1
2023-11-13 8-K 8-K 5.02,7.01,9.01 0001628280-23-038598 001-39565 231398653 34 8399877 1 1
2023-11-09 SC 13G/A JHG PLC OWNS 10.1% 0001274173-23-000092 005-91732 231391677 34 12987
2023-09-13 8-K 8-K 7.01,8.01,9.01 0001628280-23-032118 001-39565 231251141 34 680837 1 1
2023-08-21 4 FORM 4 0001628280-23-030152 4452
2023-08-18 4 FORM 4 0001628280-23-029955 4477
2023-08-18 4 FORM 4 0001628280-23-029952 7152
2023-08-18 4 FORM 4 0001628280-23-029950 5074
2023-08-18 4 FORM 4 0001628280-23-029948 7217
2023-08-18 4 FORM 4 0001628280-23-029946 5060
2023-08-17 4 FORM 4 0001628280-23-029858 4439
2023-08-17 4 FORM 4 0001628280-23-029854 7317
2023-08-17 4 FORM 4 0001628280-23-029852 5113
2023-08-11 4 FORM 4 0001577151-23-000008 4863
2023-08-11 3 FORM 3 0001577151-23-000006 368951
2023-08-11 4 FORM 4 0001628280-23-029142 8328
2023-08-09 10-Q 10-Q 0001628280-23-028569 001-39565 231155184 34 6500622 1 1
2023-08-09 8-K 8-K 2.02,9.01 0001628280-23-028406 001-39565 231153390 34 608669 1 1
2023-08-09 8-K 8-K 5.02,7.01,9.01 0001628280-23-028404 001-39565 231153374 34 499465 1 1
2023-07-18 4/A FORM 4/A 0001628280-23-025059 5644
2023-07-07 4 FORM 4 0001628280-23-024584 4761
2023-07-07 SC 13D/A SC 13D/A 0001193125-23-183780 005-91732 231076813 34 108595
2023-07-07 4 FORM 4 SUBMISSION 0000899243-23-017267 15327
2023-06-21 8-K 8-K 5.07 0001628280-23-022890 001-39565 231029857 34 204651 1 1
2023-06-16 4 FORM 4 0001628280-23-022531 4933
2023-06-16 4 FORM 4 0001628280-23-022526 4956
2023-06-16 4 FORM 4 0001628280-23-022521 4929
2023-06-16 4 FORM 4 0001628280-23-022517 4892
2023-06-16 4 FORM 4 0001628280-23-022515 4989
2023-06-16 4 FORM 4 0001628280-23-022513 4907
2023-06-16 4 FORM 4 0001628280-23-022511 4909
2023-06-16 4 FORM 4 0001628280-23-022509 7234
2023-06-02 SC 13G THE BEAUTY HEALTH COMPANY 0000902664-23-003399 005-91732 23989934 34 64878
2023-05-10 10-Q 10-Q 0001628280-23-017236 001-39565 23906600 34 6084837 1 1
2023-05-10 8-K 8-K 2.02,7.01,9.01 0001628280-23-017025 001-39565 23904351 34 4972113 1 1
2023-04-28 ARS ARS 0001818093-23-000019 001-39565 23867257 34 1305327
2023-04-28 DEFA14A DEFA14A 0001818093-23-000018 001-39565 23866125 34 2576702
2023-04-28 DEF 14A DEF 14A 0001818093-23-000017 001-39565 23866060 34 3272237 1 1
2023-04-19 4 FORM 4 0001662139-23-000005 4944
2023-04-19 3 FORM 3 0001662139-23-000004 28210
2023-04-19 8-K 8-K 5.02,7.01,9.01 0001818093-23-000014 001-39565 23830824 34 235987 1 1
2023-04-14 8-K 8-K 5.02,9.01 0001818093-23-000013 001-39565 23820942 34 232361 1 1
2023-04-06 4 FORM 4 0001628280-23-011061 4952
2023-04-06 4 FORM 4 0001628280-23-011059 357689
2023-04-06 4 FORM 4 0001628280-23-011056 356639
2023-03-06 4 FORM 4 0001818093-23-000011 4873
2023-03-06 4 FORM 4 0001818093-23-000010 357835
2023-03-06 4 FORM 4 0001818093-23-000009 356784
2023-03-02 8-K 8-K 3.02,8.01 0001818093-23-000008 001-39565 23695743 34 208492 1 1
2023-03-01 10-K 10-K 0001818093-23-000006 001-39565 23694418 34 13458251 1 1
2023-02-28 8-K 8-K 2.02,7.01,9.01 0001818093-23-000004 001-39565 23678366 34 5523403 1 1
2023-02-28 8-K 8-K 1.01,3.02,7.01 0001818093-23-000003 001-39565 23678338 34 728720 1 1
2023-02-14 SC 13G/A beautysc13ga1-021423.htm 0001013594-23-000191 005-91732 23621646 34 187430
2023-02-13 SC 13G JHG PLC OWNS >5% 0001274173-23-000076 005-91732 23615939 34 12959
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015435 005-91732 23602529 34 13019
2023-02-09 SC 13G/A filing.txt 0000315066-23-001416 005-91732 23601290 34 8223
2023-01-13 424B3 424B3 0001628280-23-000989 333-257995 23526949 33 471098
2023-01-06 8-K 8-K 5.02 0001818093-23-000002 001-39565 23515044 34 172147 1 1
2023-01-04 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001628280-22-032729,2023-01-04 9999999995-23-000028 333-257995 23509633 33 1793
2022-12-30 POS AM POS AM 0001628280-22-032729 333-257995 221502295 33 588016
2022-12-22 UPLOAD filename1.pdf 0000000000-22-013828 39417
2022-12-15 424B3 424B3 0001818093-22-000206 333-257995 221465465 33 117406
2022-12-15 10-Q/A 10-Q/A 0001818093-22-000204 001-39565 221465441 34 316125 1 1
2022-12-15 424B3 424B3 0001818093-22-000203 333-257995 221465429 33 117548
2022-12-15 10-Q/A 10-Q/A 0001818093-22-000200 001-39565 221465406 34 317064 1 1
2022-12-15 424B3 424B3 0001818093-22-000198 333-257995 221465365 33 119889
2022-12-15 10-Q/A 10-Q/A 0001818093-22-000196 001-39565 221465347 34 318575 1 1
2022-12-15 424B3 424B3 0001818093-22-000194 333-257995 221465306 33 167696
2022-12-15 10-K/A 10-K/A 0001818093-22-000193 001-39565 221465291 34 428316 1 1
2022-12-15 CORRESP filename1.htm 0001818093-22-000191 80754
2022-12-05 UPLOAD filename1.pdf 0000000000-22-013079 44981
2022-11-15 424B3 424B3 0001818093-22-000179 333-257995 221391962 33 63755
2022-11-15 8-K 8-K 1.01,2.03,9.01 0001818093-22-000177 001-39565 221391935 34 1813461 1 1
2022-11-10 424B3 424B3 0001818093-22-000174 333-257995 221375082 33 31679
2022-11-10 8-K 8-K 7.01,8.01,9.01 0001818093-22-000173 001-39565 221375079 34 191357 1 1
2022-11-09 424B3 424B3 0001818093-22-000170 333-257995 221373565 33 1426346
2022-11-09 10-Q 10-Q 0001818093-22-000169 001-39565 221373542 34 9214147 1 1
2022-11-08 8-K 8-K 2.02,7.01,9.01 0001818093-22-000166 001-39565 221367246 34 5401669 1 1
2022-09-27 424B3 424B3 0001818093-22-000159 333-257995 221267380 33 296781
2022-09-27 8-K 8-K 1.01,7.01,8.01,9.01 0001818093-22-000158 001-39565 221267367 34 509928 1 1
2022-09-15 8-K 8-K 7.01,9.01 0001818093-22-000154 001-39565 221244584 34 20395319 1 1
2022-09-02 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-09-02 16:00:00 9999999995-22-002582 333-267051 221226722 33 1781
2022-09-02 424B3 424B3 0001818093-22-000150 333-267051 221225575 33 335625
2022-08-31 CORRESP filename1.htm 0001818093-22-000148 9756
2022-08-26 UPLOAD filename1.pdf 0000000000-22-009309 40225
2022-08-26 424B3 424B3 0001818093-22-000146 333-257995 221206188 33 51827
2022-08-26 8-K 8-K 5.02 0001818093-22-000145 001-39565 221206165 34 206888 1 1
2022-08-24 S-3 S-3 0001628280-22-023622 333-267051 221192175 33 544181
2022-08-09 424B3 424B3 0001818093-22-000139 333-257995 221148725 33 1310445
2022-08-09 10-Q 10-Q 0001818093-22-000137 001-39565 221148669 34 8673069 1 1
2022-08-09 8-K 8-K 2.02,7.01,9.01 0001818093-22-000134 001-39565 221146422 34 4102861 1 1
2022-08-08 SC 13G beautysc13g-080522.htm 0001013594-22-000552 005-91732 221145052 34 223062
2022-08-03 424B3 424B3 0001818093-22-000129 333-257995 221130633 33 53985
2022-08-03 8-K/A 8-K/A 5.07 0001818093-22-000128 001-39565 221130630 34 209707 1 1
2022-06-30 4 FORM 4 0001818093-22-000125 4901
2022-06-30 4 FORM 4 0001818093-22-000123 4959
2022-06-30 4 FORM 4 0001818093-22-000121 4957
2022-06-30 4 FORM 4 0001818093-22-000119 5001
2022-06-30 4 FORM 4 0001818093-22-000117 5006
2022-06-30 4 FORM 4 0001818093-22-000115 4942
2022-06-30 4 FORM 4 0001818093-22-000113 4961
2022-06-29 424B3 424B3 0001818093-22-000111 333-257995 221055253 33 65599
2022-06-29 8-K 8-K 5.07 0001818093-22-000110 001-39565 221055232 34 222116 1 1
2022-06-29 424B3 424B3 0001818093-22-000109 333-257995 221055222 33 53345
2022-06-29 8-K/A 8-K/A 5.02 0001818093-22-000108 001-39565 221055217 34 208773 1 1
2022-06-10 424B3 424B3 0001818093-22-000102 333-257995 221007512 33 51844
2022-06-10 8-K 8-K 5.02 0001818093-22-000101 001-39565 221007510 34 206980 1 1
2022-06-09 8-K 8-K 7.01,9.01 0001818093-22-000096 001-39565 221005413 34 4172042 1 1
2022-06-07 DEFA14A DEFA14A 0001818093-22-000092 001-39565 221001821 34 17198
2022-06-06 4 FORM 4 0001818093-22-000090 4789
2022-06-06 3 FORM 3 0001818093-22-000088 13505
2022-06-06 424B3 424B3 0001818093-22-000085 333-257995 22999054 33 31618
2022-06-06 8-K 8-K 5.02,7.01,9.01 0001818093-22-000083 001-39565 22999035 34 222133 1 1
2022-05-12 DEF 14A DEF 14A 0001818093-22-000079 001-39565 22917145 34 961432
2022-05-10 8-K 8-K 7.01,9.01 0001818093-22-000076 001-39565 22910336 34 3637040 1 1
2022-05-10 424B3 424B3 0001818093-22-000074 333-257995 22909720 33 989948
2022-05-10 10-Q 10-Q 0001818093-22-000072 001-39565 22909644 34 6686895 1 1
2022-05-10 8-K 8-K 2.02,7.01,9.01 0001818093-22-000070 001-39565 22909463 34 398115 1 1
2022-05-09 424B3 424B3 0001193125-22-143933 333-257995 22902960 33 2157404
2022-05-05 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-134721,2022-05-05 9999999995-22-001317 333-257995 22898671 33 1793
2022-05-02 4 FORM 4 0001818093-22-000057 358483
2022-05-02 POS AM POS AM 0001193125-22-134721 333-257995 22878695 33 12618643 1 1
2022-03-10 8-K 8-K 7.01,9.01 0001818093-22-000055 001-39565 22727296 34 3090050 1 1
2022-03-07 424B3 424B3 0001818093-22-000053 333-257995 22719206 33 29367
2022-03-07 8-K 8-K 7.01,8.01 0001818093-22-000052 001-39565 22719192 34 229030 1 1
2022-03-01 POS EX POS EX 0001193125-22-061702 333-257995 22699907 33 55944
2022-03-01 424B3 424B3 0001818093-22-000048 333-257995 22698824 33 2882797
2022-03-01 10-K 10-K 0001818093-22-000046 001-39565 22698415 34 13790285 1 1
2022-02-22 8-K 8-K 2.02,7.01,9.01 0001818093-22-000040 001-39565 22658139 34 2977625 1 1
2022-02-14 SC 13G/A beautysc13ga1-021122.htm 0001013594-22-000234 005-91732 22634234 34 193601
2022-02-11 SC 13G/A NONE 0001567619-22-003541 005-91732 22621510 34 117072
2022-02-09 SC 13G SCHEDULE 13G 0001104659-22-016612 005-91732 22606528 34 12985
2022-02-09 4 FORM 4 0001818093-22-000035 5147
2022-02-09 3 FORM 3 0001818093-22-000033 426662
2022-02-09 SC 13G/A filing.txt 0000315066-22-000835 005-91732 22604092 34 8509
2022-02-08 4 FORM 4 0001818093-22-000031 8810
2022-02-08 4 FORM 4 0001818093-22-000029 356610
2022-02-08 4 FORM 4 0001818093-22-000027 4856
2022-02-08 4 FORM 4 0001818093-22-000025 4899
2022-02-08 4 FORM 4 0001818093-22-000023 357667
2022-01-31 4 FORM 4 0001818093-22-000021 7261
2022-01-20 424B3 424B3 0001818093-22-000019 333-257995 22540648 33 328296
2022-01-20 8-K 8-K 5.02,7.01,9.01 0001818093-22-000017 001-39565 22540646 34 592077 1 1
2022-01-10 8-K 8-K 2.01,7.01,9.01 0001818093-22-000009 001-39565 22519963 34 3805357 1 1
2022-01-04 424B3 424B3 0001818093-22-000006 333-257995 22506019 33 54988
2022-01-04 8-K 8-K 1.01,2.03,9.01 0001818093-22-000005 001-39565 22505916 34 1857763 1 1
2021-11-12 424B3 424B3 0001818093-21-000114 333-257995 211403752 33 1298751
2021-11-12 10-Q 10-Q 0001818093-21-000113 001-39565 211403669 34 8716424 1 1
2021-11-09 424B3 424B3 0001818093-21-000106 333-257995 211392116 33 26315
2021-11-09 8-K 8-K 2.02,5.02,7.01,9.01 0001818093-21-000105 001-39565 211392025 34 544666 1 1
2021-11-08 424B3 424B3 0001818093-21-000102 333-257995 211387979 33 47812
2021-11-08 8-K 8-K 8.01,9.01 0001818093-21-000100 001-39565 211387907 34 229407 1 1
2021-11-03 25-NSE xslF25X02/primary_doc.xml 0001354457-21-001280 001-39565 211375821 34 2989
2021-10-19 424B3 424B3 0001818093-21-000094 333-257995 211331150 33 51831
2021-10-19 8-K 8-K 8.01,9.01 0001818093-21-000092 001-39565 211331096 34 246612 1 1
2021-10-05 4 FORM 4 0001818093-21-000089 7913
2021-10-05 3 FORM 3 0001818093-21-000088 436311
2021-10-04 424B3 424B3 0001818093-21-000086 333-257995 211302974 33 53167
2021-10-04 8-K 8-K 8.01,9.01 0001818093-21-000084 001-39565 211302794 34 299538 1 1
2021-09-14 4 FORM 4 0001818093-21-000079 4899
2021-09-14 4 FORM 4 0001818093-21-000078 4895
2021-09-14 4 FORM 4 0001818093-21-000077 4898
2021-09-14 4 FORM 4 0001818093-21-000076 4839
2021-09-14 4 FORM 4 0001818093-21-000075 4880
2021-09-14 4 FORM 4 0001818093-21-000074 4939
2021-09-14 4 FORM 4 0001818093-21-000067 9560
2021-09-14 4 FORM 4 0001818093-21-000066 5691
2021-09-14 4 FORM 4 0001818093-21-000065 357400
2021-09-14 4 FORM 4 0001818093-21-000064 359541
2021-09-14 424B3 424B3 0001818093-21-000063 333-257995 211253076 33 67686
2021-09-14 8-K 8-K 1.01,2.03,3.02 0001818093-21-000062 001-39565 211253007 34 1712287 1 1
2021-09-10 S-8 S-8 0001818093-21-000059 333-259430 211245998 33 186559
2021-09-10 424B3 424B3 0001818093-21-000054 333-257995 211245892 33 50782
2021-09-10 8-K 8-K 8.01,9.01 0001818093-21-000052 001-39565 211245701 34 248694 1 1
2021-09-08 424B3 424B3 0001818093-21-000047 333-257995 211242728 33 50786
2021-09-08 8-K 8-K 8.01,9.01 0001818093-21-000045 001-39565 211242586 34 245392 1 1
2021-08-27 4 FORM 4 SUBMISSION 0000899243-21-034446 16201
2021-08-26 4 FORM 4 0001818093-21-000041 357819
2021-08-26 4 FORM 4 0001818093-21-000040 358904
2021-08-26 4 FORM 4 0001818093-21-000039 356761
2021-08-13 4 FORM 4 0001818093-21-000038 419254
2021-08-13 3 FORM 3 0001818093-21-000037 416962
2021-08-13 424B3 424B3 0001818093-21-000036 333-257995 211173462 33 1185720
2021-08-13 10-Q 10-Q 0001818093-21-000034 001-39565 211172802 34 6880704 1 1
2021-08-10 8-K 8-K 2.02,9.01 0001818093-21-000030 001-39565 211159942 34 507938 1 1
2021-07-26 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-07-26 16:00:00 9999999995-21-002921 333-257995 211115788 33 1781
2021-07-26 424B5 424B5 0001193125-21-224443 333-257995 211114913 33 3023081
2021-07-22 UPLOAD filename1.pdf 0000000000-21-009068 40170
2021-07-22 CORRESP filename1.htm 0001818093-21-000028 8095
2021-07-19 4 FORM 4 0001818093-21-000027 357803
2021-07-19 4 FORM 4 0001818093-21-000026 356745
2021-07-19 4 FORM 4 0001818093-21-000025 358888
2021-07-19 SC 13D/A SC 13D/A 0001193125-21-218737 005-91732 211098622 34 133277
2021-07-19 4 FORM 4 SUBMISSION 0000899243-21-028843 16346
2021-07-19 S-1 S-1 0001193125-21-217697 333-257995 211096635 33 13292723 1
2021-07-12 8-K 8-K 2.01,4.01,9.01 0001818093-21-000021 001-39565 211083851 34 1178716
2021-07-01 10-Q 10-Q 0001193125-21-206381 001-39565 211066432 34 3181228 1
2021-06-21 3 FORM 3 0001818093-21-000018 4942
2021-06-16 8-K 8-K 5.02 0001818093-21-000016 001-39565 211022215 34 27406
2021-06-10 SC 13G/A filing.txt 0000315066-21-001578 005-91732 211007361 34 8529
2021-06-10 8-K 8-K 7.01 0001818093-21-000015 001-39565 211006900 34 4865189
2021-06-07 SC 13G beautyhealth13g-052821.htm 0001013594-21-000505 005-91732 211000350 34 228623
2021-05-28 10-K/A 10-K/A 0001193125-21-175590 001-39565 21974492 34 3821781 1
2021-05-21 4 FORM 4 0001818093-21-000014 358769
2021-05-21 4 FORM 4 0001818093-21-000013 356626
2021-05-21 4 FORM 4 0001818093-21-000012 357684
2021-05-21 4 FORM 4 SUBMISSION 0000899243-21-020352 16400
2021-05-21 SC 13D/A SC 13D/A 0001193125-21-169328 005-91732 21949454 34 140289
2021-05-20 8-K 8-K 3.01,8.01,9.01 0001818093-21-000011 001-39565 21944534 34 47398
2021-05-19 SC 13G/A SC 13G/A 0001628280-21-010624 005-91732 21937747 34 58243
2021-05-18 4 FORM 4 0001818093-21-000010 14413
2021-05-18 4 FORM 4 0001818093-21-000009 8030
2021-05-18 NT 10-Q NT 10-Q 0001818093-21-000007 001-39565 21936338 34 27838
2021-05-14 SC 13D SC 13D 0001193125-21-162040 005-91732 21925010 34 288798
2021-05-13 8-K 8-K 2.02,9.01 0001818093-21-000006 001-39565 21919640 34 385726 1 1
2021-05-10 4 FORM 4 SUBMISSION 0000899243-21-019004 5666
2021-05-10 4 FORM 4 SUBMISSION 0000899243-21-019002 5703
2021-05-10 4 FORM 4 SUBMISSION 0000899243-21-019001 5733
2021-05-10 4 FORM 4 SUBMISSION 0000899243-21-018999 10488
2021-05-10 8-K 8-K 1.01,2.01,3.02,3.03,4.02,5.02,5.03,5.06,9.01 0001193125-21-156433 001-39565 21908512 34 1511053
2021-05-10 3 FORM 3 SUBMISSION 0000899243-21-018994 2987
2021-05-10 3 FORM 3 SUBMISSION 0000899243-21-018988 2928
2021-05-10 3 FORM 3 SUBMISSION 0000899243-21-018984 2990
2021-05-10 3 FORM 3 SUBMISSION 0000899243-21-018983 3024
2021-05-10 3 FORM 3 SUBMISSION 0000899243-21-018982 2943
2021-05-10 3 FORM 3 SUBMISSION 0000899243-21-018977 19770
2021-05-10 3 FORM 3 SUBMISSION 0000899243-21-018974 2956
2021-05-05 25-NSE xslF25X02/primary_doc.xml 0001354457-21-000542 001-39565 21893292 34 3007
2021-05-05 8-K 8-K 7.01,9.01 0001193125-21-150753 001-39565 21891132 34 35683
2021-04-30 8-K 8-K 5.02,5.07,9.01 0001193125-21-145386 001-39565 21879178 34 247721
2021-04-27 8-K/A 8-K/A 8.01 0001193125-21-133043 001-39565 21856082 34 42991
2021-04-27 DEFA14A 8-K/A 0001193125-21-133044 001-39565 21856078 34 42928
2021-04-26 8-K 8-K 8.01 0001193125-21-131202 001-39565 21853294 34 48834
2021-04-26 DEFA14A 8-K 0001193125-21-131204 001-39565 21853286 34 48777
2021-04-21 DEFA14A DEFA14A 0001193125-21-123677 001-39565 21839623 34 47252
2021-04-21 8-K 8-K 7.01,9.01 0001193125-21-123671 001-39565 21839621 34 243195 1 1
2021-04-19 DEFA14A DEFA14A 0001193125-21-121424 001-39565 21835526 34 40510
2021-04-19 8-K 8-K 8.01 0001193125-21-121423 001-39565 21835493 34 234207 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (374 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 6.54M 2026-11-02 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
dei EntityPublicFloat Entity Public Float USD 158.40M 2025-06-30 2025 FY 10-K 2026-03-12 0001628280-26-017376
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 301.00M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001683168-26-003189
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.20M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001683168-26-003189
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.31M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001683168-26-003189
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 142.22 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001683168-26-003189
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 10.82 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001683168-26-003189
us-gaap AcceleratedShareRepurchaseProgramAdjustment Accelerated Share Repurchase Program, Adjustment USD -2.24M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 15.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 18.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AccountsReceivableRelatedParties Accounts Receivable, Related Parties USD 394,000 2021-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 74,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 35.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 1.72M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038926
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 10.71M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AccruedSalesCommissionCurrent Accrued Sales Commission, Current USD 3.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 4.41M 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 585.15M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 43,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.44M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 22.54M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 24.76M 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.08M 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap AdvertisingExpense Advertising Expense USD 6.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 20.85M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-047310
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 2.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 5.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap AmortizationOfBelowMarketLease Amortization of Below Market Lease USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 14.85M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 2.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 10.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 24.67M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap Assets Assets USD 389.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap AssetsCurrent Assets, Current USD 201.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 0.5 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 90,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 523.02M 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -511,921 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 112.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -120.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 320.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 6.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 6.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -10.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ContractualObligation Contractual Obligation USD 20.30M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 19.90M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ConvertibleDebt Convertible Debt USD 242.96M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 242.96M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap CostOfRevenue Cost of Revenue USD 65.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 146,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 1.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 224,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 0.77 2024-01-01 2024-01-31 2024 Q1 10-Q 2024-05-09 0001628280-24-022336
us-gaap DebtInstrumentRepurchasedFaceAmount Debt Instrument, Repurchased Face Amount USD 0 2025-03-31 2025 Q1 10-Q 2025-05-08 0001628280-25-023922
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 16.10M 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 7.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 1.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 2.16M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 65,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 1.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 8.56M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 731,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 412,609 2020-09-30 2021 Q3 10-Q 2020-11-16 0001213900-20-037218
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 44.94M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.59M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 4.85M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 1.53M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 15.50M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 104,712 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 39.10M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.58M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 1.12M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 28,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.42M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 4.03M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges USD 43,197 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross USD 20,625 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 34.84M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 171,000 2023-12-31 2024 FY 10-K 2025-03-12 0001628280-25-012407
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 2.26M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.89M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 2.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap Depreciation Depreciation USD 1.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap DilutiveSecuritiesEffectOnBasicEarningsPerShareOther Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap DueToAffiliateCurrent Due to Affiliate, Current USD 0 2023-03-31 2023 Q1 10-Q 2023-05-10 0001628280-23-017236
us-gaap DueToOtherRelatedPartiesClassifiedCurrent Due to Other Related Parties, Current USD 228,723 2020-09-30 2021 Q3 10-Q 2020-11-16 0001213900-20-037218
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 1.18 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.603 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.034 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Percent pure -0.005 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.002 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.123 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.315 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.036 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.038 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.035 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -113,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 15.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 19.40M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001628280-25-050315
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 8.60M 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 17.94M 2020-10-03 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 131.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 2.33M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 13.46M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.85M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 2.36M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 4.46M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 11.29M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 159.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 27.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -1.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -2.41M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -5.24M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD -2.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap GainLossOnRepurchaseOfDebtInstrument Gain (Loss) on Repurchase of Debt Instrument USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -2.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 1.02M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001628280-26-032326
us-gaap GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 65.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap Goodwill Goodwill USD 126.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 26.60M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -497,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap GrossProfit Gross Profit USD 140.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -12.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -8.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 6.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 72,209 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 1.83M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 44,562 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 84,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.01M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 296,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -64,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 729,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -1.06M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 227,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 208,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 108,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 15.78M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 8.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 1.28M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -3.36M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap IncreaseDecreaseInDueToOtherRelatedParties Increase (Decrease) in Due to Other Related Parties USD 228,723 2020-07-08 2020-09-30 2021 Q3 10-Q 2020-11-16 0001213900-20-037218
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 26.94M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 3.67M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 160,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 10.00M 2026-02-01 2026-02-28 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 8.04M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 6.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 17.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -42,424 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-12 0001628280-25-012407
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001628280-26-054476
us-gaap InterestExpense Interest Expense USD 3.03M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001628280-24-022336
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 18.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -13.39M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap InterestIncomeOther Interest Income, Other USD 9.18M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap InterestIncomeSecuritiesOtherUSGovernment Interest Income, Securities, Other US Government USD 85,152 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 14.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap InterestPayableCurrent Interest Payable, Current USD 7.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 28.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap InventoryNet Inventory, Net USD 46.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 17.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap InventoryWriteDown Inventory Write-down USD 1.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 4.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 3.70M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap LeaseCost Lease, Cost USD 6.64M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 14.00M 2026-02-28 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.96M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.74M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.09M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.10M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.18M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.55M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.26M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap Liabilities Liabilities USD 333.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 389.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap LiabilitiesCurrent Liabilities, Current USD 69.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap LitigationSettlementAmountAwardedFromOtherParty Litigation Settlement, Amount Awarded from Other Party USD 1.40M 2023-09-18 2024 Q1 10-Q 2024-05-09 0001628280-24-022336
us-gaap LongTermDebt Long-term Debt USD 363.39M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001628280-25-050315
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 18.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap LossContingencyReceivableCurrent Loss Contingency, Receivable, Current USD 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap LossOnContractTermination Loss on Contract Termination USD 8.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-12 0001628280-25-012407
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 460.18M 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 1,036 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -124.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -3.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 8.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -10.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -10.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -10.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1 Noncash or Part Noncash Acquisition, Accounts Receivable Acquired USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap NoncashOrPartNoncashAcquisitionDebtAssumed1 Noncash or Part Noncash Acquisition, Debt Assumed USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001818093-22-000169
us-gaap NoncurrentAssets Long-Lived Assets USD 14.11M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 62.95M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001818093-22-000169
us-gaap NontradeReceivables Nontrade Receivables USD 1.00M 2024-12-31 2024 FY 10-K 2025-03-12 0001628280-25-012407
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap NumberOfBusinessesAcquired Number of Businesses Acquired business 4 2021-06-01 2021-07-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap NumberOfReportingUnits Number of Reporting Units reporting_unit 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 602,319 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap OperatingExpenses Operating Expenses USD 134.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 6.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OperatingLeaseCost Operating Lease, Cost USD 5.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 14.37M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 17.69M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OperatingLeasePayments Operating Lease, Payments USD 5.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 19.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 4.56M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 9.88M 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.62M 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 669,000 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 2.05M 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.11M 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.43M 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.054 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 3.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OtherAmortizationOfDeferredCharges Amortization of Other Deferred Charges USD 3.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 10.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -288,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1.51M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001628280-23-017236
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 98,212 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001213900-21-016237
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 4.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap PaymentsForDerivativeInstrumentFinancingActivities Payments for Derivative Instrument, Financing Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap PaymentsForHedgeFinancingActivities Payments for Hedge, Financing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-12 0001628280-25-012407
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 16.10M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 2.00M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 465,909 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 3.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 460.00M 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 744,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 22.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 7.75M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001818093-21-000113
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 25,000 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 350.00M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap ProceedsFromLegalSettlements Proceeds from Legal Settlements USD 100,000 2023-10-13 2024 Q1 10-Q 2024-05-09 0001628280-24-022336
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 450.80M 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 229,886 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 261,386 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap ProductWarrantyAccrual Standard and Extended Product Warranty Accrual USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 1.00M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap ProductWarrantyAccrualNoncurrent Product Warranty Accrual, Noncurrent USD 2.00M 2023-12-31 2024 FY 10-K 2025-03-12 0001628280-25-012407
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization USD 23.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization USD 1.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 9.19M 2020-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap RedeemableNoncontrollingInterestEquityCommonCarryingAmount Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount USD 460.04M 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 103.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 261,386 2020-07-08 2020-12-31 2020 FY 10-K/A 2021-05-28 0001193125-21-175590
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap RestrictedCash Restricted Cash USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap RestructuringCharges Restructuring Charges USD 7.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap RestructuringReserve Restructuring Reserve USD 3.00M 2025-03-31 2025 Q1 10-Q 2025-05-08 0001628280-25-023922
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -527.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 206.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 551,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 350.00M 2021-05-04 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 3.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 64.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 1.40M 2020-05-01 2020-05-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 5.90M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-12 0001628280-25-012407
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 121,996 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 269.39 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.84 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001818093-22-000046
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 121,996 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 269.39 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 121,996 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 269.39 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 375.2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 1.66M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap SponsorFees Sponsor Fees USD 30,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 55.76M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap StockIssued1 Stock Issued USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 11.50M 2021-05-04 2023 Q1 10-Q 2023-05-10 0001628280-23-017236
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 35.00M 2021-05-04 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 1.50T 2020-07-08 2020-09-30 2021 Q3 10-Q 2020-11-16 0001213900-20-037218
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 457.72M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 629,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 136.57M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-12 0001628280-24-010638
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 14.00M 2020-07-08 2020-12-31 2020 FY 10-K 2021-03-18 0001213900-21-016237
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationForfeited Shares Issued, Value, Share-based Payment Arrangement, Forfeited USD 5.10M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001628280-25-050315
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD -36,188 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 30.46M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 4.80M 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038926
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 11.10M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001628280-25-050315
us-gaap UnrealizedGainLossOnSecurities Unrealized Gain (Loss) on Securities USD 1,036 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 121,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 422,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 700,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017376
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001818093-23-000006
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 139,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001628280-25-050315
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 6.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 11.50M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-07-01 0001193125-21-206381
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 6.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071173
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 100,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001628280-26-054476

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →